http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022043381-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf511a0f6101748ace5d31c4f8a2314f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-70
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
filingDate 2021-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d4eb3ef58c80ed5346d329d50fc84cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8554e685975268089f45e6401af0072e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3768083fe6e5803d902c4f71348821d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54ff9c9a51e813e8f942ee7e2b7505c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fb55505e604fd87c7d6bc0e56a26564
publicationDate 2022-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022043381-A1
titleOfInvention Anti-fibrotic combination
abstract The invention relates to a method of treating or preventing a disease or condition associated with or characterised by fibrosis, comprising administering an effective amount of a chymase inhibitor simultaneously or sequentially with an effective amount of a tryptase inhibitor, to a subject in need thereof. Also provided are chymase and tryptase inhibitors for use in these methods.
priorityDate 2020-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017017474-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1384715-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008102397-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02087591-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51380892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2882

Total number of triples: 50.